ZLC6-49
ZLC6-49 is a CRBN-dependent FLT3 PROTAC degrader with a DC50 of 0.74 nM. ZLC6-49 induces apoptosis and G0/G1 cell cycle arrest, inhibits FLT3 downstream signaling by reducing STAT5 and ERK phosphorylation levels, and exhibits antiproliferative activity. ZLC6-49 can be used for research on acute myeloid leukemia (AML).
(Pink: FLT3 ligand (HY-12432); Blue: Cereblon ligand (HY-14658); Black: linker).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3069174-12-2
- Formel: C45H57N11O7
- Molecular Weight:864.00
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle PROTACs Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
FLT3 0.74 nM (DC50) |
STAT5 |
ERK |
CRBN |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MV4-11 | IC50 |
0.37 nM
|
Antiproliferative activity against MV4-11 cells assessed as viability reduction incubated 72 hrs by CCK-8 assay.
Antiproliferative activity against MV4-11 cells assessed as viability reduction incubated 72 hrs by CCK-8 assay.
|
42772077 |
In Vitro
ZLC6-49 accelerates FLT3 turnover in MV4-11 cells, shortening the FLT3 half-life to less than 3 h[1].
ZLC6-49 (1 nM; 6 h) induces FLT3 degradation in MV4-11 cells in a CRBN- and proteasome-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MV4-11 cells
-
Concentration:1 nM
-
Incubation Time:6 h
-
Result:FLT3 degradation was abrogated by MG132 and MLN4924, but not by Bafilomycin A1 (HY-100558).
Gilteritinib (HY-12432) and Lenalidomide (HY-A0003) rescued FLT3 degradation.
-
Cell Line:MV4-11 cells
-
Concentration:0.08, 0.4, 2, 10, 50 nM
-
Incubation Time:24 h
-
Result:Phosphorylation of FLT3, STAT5, and ERK was dose-dependently decreased in MV4-11 cells.
-
Cell Line:MV4-11 cells
-
Concentration:0.4, 2, 10, 50 nM
-
Incubation Time:48 h
-
Result:MV4-11 apoptosis was induced in a concentration-dependent manner.
At 50 nM, cleaved caspase 3 levels were increased.
-
Cell Line:MV4-11 cells
-
Concentration:0.08, 0.4, 2 nM
-
Incubation Time:24 h
-
Result:G0/G1-phase arrest was dose-dependently induced.
The G0/G1 population increased to 85.1% at 2 nM.
- Kinase activity and phosphorylation assays
- Western Blot
- Detection of Apoptosis
- TUNEL staining for apoptotic DNA fragmentation
- Flow cytometric DNA-content cell-cycle staining
- Annexin V plus membrane-impermeant dye apoptosis staining
- BrdU Incorporation Assay
- Apoptosis Solutions
- Protocol for Cell Cycle
- Protocol for Kinase activity and phosphorylation assays
- Cell Viability Determination by MTT Colorimetric Assay
Parmacokinetics
Chemical Information
-
CAS. Nr. 3069174-12-2
-
Molecular Weight 864.00
-
Formel C45H57N11O7
-
SMILES
NC(C(N=C1CC)=C(NC2=CC=C(N3CCC(N4CCN(CC5CN(C6=CC=C7C(C(N(C8CCC(NC8=O)=O)C7=O)=O)=C6)C5)CC4)CC3)C(OC)=C2)N=C1NC9CCOCC9)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)